Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    TED12414
Show Display Options
Rank Status Study
1 Recruiting Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
Condition: Neoplasm Malignant
Interventions: Drug: SAR245408;   Drug: SAR245409

Indicates status has not been verified in more than two years